Search
for
Sort by
Research 661–690 of 1000+
- YKL-40 a sensitive biomarker for early androgenetic alopecia and early hidden metabolic syndrome
- Transcriptomic crossroads: Decoding genes and pathways that connect alopecia areata with chronic inflammatory skin disorders
- Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia
- Scalp Microbiome Composition in Young Women: Associations with Scalp Type, Sensitivity, and Lifestyle Factors
- The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
- Directional Association Between Irritable Bowel Syndrome and Dermatological Disease: A Large-Scale Retrospective Study
- Ophthalmologic Comorbidities in Alopecia Areata
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- E-Poster
- Hydrobiome of Thermal Waters: Potential Use in Dermocosmetics
- Phytochemical profiling and evaluation of the anti-aging and anti-inflammatory potential of cultivated Eclipta alba (L.)
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Table 2_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.docx
- Table 1_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.docx